查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1853389

动物即时诊断市场（按动物类型、检测类型、最终用户、技术、应用和样本类型划分）—2025-2032年全球预测

Veterinary Point Of Care Diagnostics Market by Animal Type, Test Type, End User, Technology, Application, Sample Type - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，兽医即时诊断市场规模将达到 50.3 亿美元，复合年增长率为 12.58%。

关键市场统计数据
基准年2024年 19.4亿美元
预计年份：2025年 21.9亿美元
预测年份 2032 50.3亿美元
复合年增长率（%） 12.58%

本文简要介绍了床边诊断和烧伤场诊断如何重塑当今的兽医医疗服务和临床决策。

动物照护现场诊断正迅速从一种辅助设备发展成为动物医疗保健服务的核心要素。兽医和畜牧管理者越来越需要在床边或畜舍获得快速可靠的检测结果，以便立即做出临床决策、提高诊疗效率并减少集中式实验室带来的后勤障碍。携带式分析化学、小型化分析仪和整合数位输出技术的进步缩短了周转时间，使得在治疗时间和地点即可获得有效的诊断结果成为可能。

这一演变是由多种因素共同推动的。伴侣动物数量的增长以及人们对宠物健康投入意愿的提高正在重塑临床预期；而在畜牧业领域，优化牛健康和生物安全的压力日益增大，促使农场管理者采用更积极主动的诊断流程。同时，免疫测量、分子平台和感测器技术的成熟使得在小型设备中实现更高的分析性能成为可能。部分地区的监管政策更加明确，兽医专业人员的训练课程也更加完善，降低了技术应用的门槛。

综上所述，这些动态因素正助力兽医缩小从临床怀疑到检验的差距，从而支持更早的干预、更有针对性的治疗，并显着改善动物福利和营运效率。本执行摘要探讨了变革性转变、细分市场的细微差别、区域差异、公司应对措施，以及领导者在进入这个充满活力的市场时应考虑的策略建议。

本文分析了正在重塑照护现场兽医诊断和行业经营模式的关键技术、临床和商业性变革。

兽医照护现场诊断领域正经历一场变革性的转变，重塑价值链、临床工作流程和投资重点。其中一个显着的变化是从一次性侧向流动检测设备转向更先进的基于读卡器和无读卡器的检测设备，这些设备能够实现定量输出、互联互通和结果标准化。这项转变有助于与诊所管理系统和远距分诊服务集成，使临床医生能够做出基于数据的可靠决策，并扩大远距和门诊环境下的诊断范围。

同时，由于简化的样本製备、等温扩增和基于试剂盒的耗材，分子诊断正从中心实验室转移到更贴近患者的场所。更灵敏的检测方法的广泛应用正在改变伴侣动物和牲畜感染疾病管理的诊断路径，从而实现更快的疫情控制和更有针对性的治疗。人工智慧和云端分析为原始输出结果增添了一层解读空间，帮助临床医生确定病例优先顺序并更早识别流行病学讯号。

随着经营模式的演变，製造商和经销商正采用以服务为中心的策略，将仪器与试剂、校准服务和数位订阅捆绑销售，以锁定终身价值并提高可预测性。这种转变迫使传统供应商加快创新週期，并要求新参与企业证明其具备临床检验、符合法规要求以及经济高效的服务营运能力。最终，这将形成一个更互联、灵活且具有临床影响力的兽医诊断生态系统。

2025年关税调整如何改变了兽医诊断设备和耗材的供应链、定价策略和采购选择

2025年实施的关税调整的累积影响对整个兽医诊断生态系统的筹资策略、定价机制和供应链韧性产生了重大影响。关税波动增加了进口分析仪、读取模组和关键试剂的到岸成本，这些产品通常在海外高度专业化的工厂生产。对于利润微薄的终端用户，例如门诊和小型诊断实验室，成本增加迫使他们重新调整服务价格并延长资本设备的更换週期。

製造商和经销商的应对措施包括加速本地化和双源筹资策略。一些企业将大批量消耗品的生产转移到区域性代工製造商，而其他企业则优先考虑库存避险和多层分销，以缓衝短期波动。虽然这些策略提高了应对力，但也增加了营运成本，并使库存管理更加复杂。同时，关税相关的成本压力促使企业重新设计产品，以减少对高关税零件的依赖，并优化模组化组装的供应链，使其更靠近主要终端用户市场。

从市场进入角度来看，关税变化导致价值提案碎片化。供应商强调整体拥有成本、服务可靠性和整合耗材包，以在受关税影响的环境下证明定价合理性。因此，行业变得更加防御性，并进行了战略多元化；区域製造商通过利用本地生产而不是依赖受关税影响的进口产品来提升市场份额；而灵活的供应商则通过提供差异化服务和订阅模式，看到了降低短期价格敏感性的机会。

将物种、诊断方式、终端用户画像和样本采集路径与可操作的产品和渠道策略联繫起来的全面细分洞察

透过从临床、技术和商业性等多个角度审视市场，可以发现关键的细分市场洞察。依动物类型划分，需求模式可分为伴侣动物和牲畜两大类。在伴侣动物领域，猫和狗由于看护者期望和临床表现的差异，呈现出不同的诊断应用场景；而牲畜的需求涵盖牛、马、家禽和猪，它们往往更注重检测通量、生物安全性和批量检测流程。这些不同的需求会影响套件配方、分析仪通量和服务模式。

按检测类型划分，生化检测（包括生化和电解质分析仪）仍然是常规代谢筛检和重症加护的基础。血液学仪器（例如血球计数器和血红蛋白分析仪）是贫血检测和感染疾病监测的核心。免疫测量（如酵素连结免疫横向流动化验）提供快速简便的筛检，而分子诊断设备则在疫情爆发情况下提供更高的病原体检测灵敏度和特异性。

最终使用者涵盖范围广泛，包括诊断实验室、医院/诊所和研究机构，每个机构的采购週期、验证要求和预算各不相同。技术选项分为两类：一类是基于读卡机的系统，提供定量和连接功能；另一类是无读卡机系统，优先考虑简单性和低成本。应用领域涵盖心臟监测、重症加护、感染疾病检测和代谢筛检，常见样本类型包括血液、粪便、牛奶、唾液和尿液。了解这些细分维度如何相互交织，对于产品设计和市场推广优先顺序至关重要，因为分析仪功能、耗材规格和服务的最佳组合会因动物种类、测试目标和饲养环境的不同而显着变化。

区域差异化视角，着重阐述全球主要区域在临床需求、监管细微差别和商业性路径上的差异

区域动态影响市场采纳曲线、监管路径和商业性优先事项，供应商和投资者在规划市场进入和扩张时必须考虑这些因素。在美洲，市场需求主要集中在先进的伴侣动物护理和一体化的诊所工作流程上，这得益于强大的私人兽医网络以及对高端诊断技术的投资意愿。该地区的市场新参与企业正着重强调仪器性能、数位化整合和耗材捆绑销售等差异化优势，同时，远端保健诊断服务也呈现成长动能。

在欧洲、中东和非洲，买家面临着监管环境、报销标准和动物保健服务基础设施等方面的显着差异。西方市场往往更注重临床的复杂性和监管主导的检验要求，而中东和北非市场则更重视产品的稳健性、成本效益和简化的培训模式。这些区域差异要求客製化的产品线和灵活的销售条款，以适应不同的采购能力和临床实践。

在亚太地区，人口密度高、畜牧业蓬勃发展以及宠物饲养率不断上升，推动了对扩充性诊断技术的需求。多个市场正在快速采用行动诊断和云端分析技术，而一些国家强大的本地製造业基础也为具有成本竞争力的耗材的快速部署提供了支援。整体而言，为了实现永续的普及应用，区域策略必须在利用全球技术平台的同时，兼顾区域产品客製化、监管协调和经销伙伴。

对现有企业、兽医专业公司和创新新兴企业如何竞争与合作以获得设备、耗材和服务方面的价值进行策略评估。

动物即时诊断领域呈现出多元化的格局，既有成熟的诊断服务提供商，也有专注于兽医领域的专业公司，还有新兴企业，它们各自采取不同的规模化发展路径。成熟的设备製造商利用其成熟的分销和服务能力，向上提升销售仪器和耗材整合解决方案；而专注于兽医领域的公司则专注于临床检验和产品设计，使其与兽医的工作流程相契合。新兴企业通常专注于单一的高价值应用、新型检测化学方法或能够简化结果解读和报告的数位化技术。

策略活动的核心是伙伴关係、授权协议和共同开发契约，这些协议能够加快产品上市速度并分散开发风险。常见的做法包括与兽医院集团合作试行新的诊断方法，与契约製造製造商签订合约以实现本地化生产，以及与软体供应商合作将连接性和分析功能嵌入到临床常规流程中。竞争优势越来越依赖提供端到端价值的能力，包括可靠的硬体、高效的耗材、快速反应的服务以及能够提升临床效用的数据工具。

那些签订长期服务协议、优化试剂物流并提供针对性临床医生教育计画的公司往往能获得较高的客户留存率和更高的终身收益。相反，那些对本地支援投入不足或未能清楚展示临床效益的公司，其产品推广週期则会更长。评估伙伴关係的相关人员应重点关注营运准备、品质体係以及支援多物种检验的能力，以最大限度地提高跨领域适用性。

为供应商和投资者提供可操作的策略建议，以增强其兽医诊断产品系列、供应链、服务模式和监管参与。

产业领导者可以透过实施一系列有针对性的策略行动来加速技术普及并确保可持续的竞争优势：能够相容于多种检测类型和样本基质的平台可以降低单位风险并提高生命週期收益。投资开发无需读卡机的低成本、大批量应用平台，同时保留用于定量互联工作流程的读卡机产品，可扩大市场覆盖范围并弹性价格设定。

第二，透过区域製造伙伴关係和多边采购协议加强供应链韧性，以降低关税波动和物流中断带来的风险。引入本地组装和区域试剂生产可以缩短前置作业时间，并提高利润稳定性。第三，透过整合培训、校准和数位化解读支援的服务模式实现差异化。基于订阅的耗材计划，包括自动补货和远端监控，可以提高客户维繫，并稳定收益和预测。

第四，我们将积极与监管机构和关键意见领袖沟通，加快临床检验，并制定清晰的市场推广路径。第五，我们将建构符合终端用户经济状况的商业模式，提供分级仪器、捆绑式耗材和灵活的融资方案，以满足兽医诊所、诊断实验室和研究机构的不同预算需求。最后，我们将整合数据能力，将诊断结果转化为可操作的临床资讯和人群健康洞察，从而增强我们对购买者和支付者的价值提案。

对用于建构可操作情报的主要和次要研究方法、专家检验流程以及资料三角测量技术进行透明概述

本分析的调查方法结合了初步质性研究和严谨的二次检验，以确保研究结果具有临床相关性和实际应用价值。初步研究包括对执业兽医、实验室主任、动物饲养经理和产品开发负责人进行结构化访谈，重点关注应用案例、采购决策标准和售后支援期望。这些访谈真实反映了现有诊断产品的可接受性、工作流程整合情况以及痛点。

二次研究利用技术文献、监管指导文件、专利和公开的临床检验研究来支持​​性能声明并确定技术发展轨迹。采用数据三角测量法来协调各相关人员的观点差异，并检验实务中观察到的趋势。透过将临床应用案例与设备特性和耗材形式进行交叉比对，进行細項分析，以确定产品满足最终用户需求的领域。

调查方法的限制包括不同地区监管透明度的差异以及不同动物物种适应成熟度的差异，这可能会影响战术性结论的普遍适用性。为了减轻这些局限性，我们透过情境分析对研究结果进行了压力测试，并由独立的行业专家进行同行评审，以提高所提建议的稳健性。

总结全文，重点阐述技术、服务提供和营运韧性之间的相互作用，这将决定兽医诊断的长期成功。

总之，兽医照护现场技术正步入实用化成熟阶段，技术能力、服务设计和商业性弹性将决定最终的成败。可携式分子检测工具、改进的免疫测量方法和数位化读数平台的融合，为诊断技术从零星应用转向在伴侣动物诊所和畜牧业的常规应用提供了清晰的路径。然而，能否持续普及应用取决于能否解决终端使用者的经济问题、建构稳健的供应链，以及在各种环境下展现可衡量的临床效用。

将模组化产品设计与强大的本地支援、智慧服务模式以及有助于获得监管部门认可的伙伴关係关係相结合的组织，最有可能创造持久价值。关税压力和区域差异凸显了灵活的製造地和适应性强的商业条款的重要性。最终，最具吸引力的价值提案是将快速、准确的诊断与改善临床结果、减少营运浪费和加强人群健康监测联繫起来，从而使即时检测（POC​​）成为动物医疗保健运作整体不可或缺的一部分。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 将人工智慧影像分析技术整合到手持式兽医诊断设备中，以提高准确性和速度
  • 宠物综合现场疾病检测中多重免疫检测试剂盒的应用日益广泛
  • 扩大携带式分子检测平台的规模，以便在现场环境中快速检测通用感染疾病。
  • 兽医诊所正在加大对无线连接的投资，以实现即时远端监控和远端医疗。
  • 推出一款基于智慧型手机的诊断感测器，用于早期检测牲畜代谢紊乱疾病。
  • 能够以极少的样本量进行测量的照护现场生化分析仪对于新生儿和异宠来说变得越来越重要。
  • 农业技术和兽医诊断公司合作开发用于牲畜健康监测的感测器阵列
  • 开发用于农场抗菌素抗药性标记物检测的电池供电微流体装置
  • 兽医诊所越来越多地使用基于云端基础的分析技术，将即时检验（POC）数据与电子健康记录相结合，进行趋势分析。

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：以动物类型分類的动物即时诊断市场

  • 伴侣动物
    • 猫
    • 狗
  • 家畜
    • 牛
    • 马
    • 家禽
    • 猪

9. 按检测类型分類的动物即时诊断市场

  • 生物化学
    • 化学分析仪
    • 电解质分析仪
  • 血液学
    • 细胞计数器
    • 血红素分析仪
  • 免疫检测
    • 伊丽莎
    • 横向流动化验
  • 分子诊断

第十章：以最终用户分類的动物即时诊断市场

  • 诊断实验室
  • 医院和诊所
  • 研究机构

第十一章：按技术分類的动物即时诊断市场

  • 领导者
  • 无领导

第十二章：按应用分類的动物即时诊断市场

  • 心臟监测
  • 加护治疗
  • 感染疾病
  • 代谢筛检

第十三章：依样本类型分類的动物即时诊断市场

  • 血
  • 屎
  • 牛奶
  • 唾液
  • 尿

第十四章：按地区分類的兽医即时诊断市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 动物即时诊断市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章：各国动物即时诊断市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • IDEXX Laboratories, Inc.
    • Zoetis Inc.
    • Heska Corporation
    • Abaxis, Inc.
    • Mars, Inc.
    • FUJIFILM Holdings Corporation
    • Nova Biomedical Corporation
    • bioMerieux SA
    • Abbott Laboratories
    • QIAGEN NV
Product Code: MRR-3A2E844FD625

The Veterinary Point Of Care Diagnostics Market is projected to grow by USD 5.03 billion at a CAGR of 12.58% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 1.94 billion
Estimated Year [2025] USD 2.19 billion
Forecast Year [2032] USD 5.03 billion
CAGR (%) 12.58%

A succinct introduction framing how bedside and barnside diagnostics are reshaping veterinary care delivery and clinical decision making today

Veterinary point-of-care diagnostics are rapidly transitioning from niche adjuncts to core elements of animal healthcare delivery. Vets and livestock managers increasingly demand fast, reliable test results at the bedside or barn to enable immediate clinical decisions, improve throughput, and reduce the logistical friction associated with centralized laboratories. Advances in portable assay chemistry, miniaturized analyzers, and integrated digital output have compressed turnaround times and allowed for meaningful diagnostics at the time and place of care.

This evolution is driven by several converging forces. Rising companion animal ownership and heightened willingness to invest in pet health are reshaping clinical expectations, while intensifying pressure to optimize herd health and biosecurity in livestock sectors is pushing farm managers to adopt more proactive diagnostic workflows. Concurrently, technological maturation across immunoassays, molecular platforms, and sensor technologies has enabled greater analytical performance in compact formats. Regulatory clarity in some jurisdictions and expanding training programs for veterinary professionals are reducing barriers to adoption.

Taken together, these dynamics are enabling practitioners to close the gap between clinical suspicion and verification, supporting earlier interventions, more targeted therapeutics, and measurable improvements in animal welfare and operational efficiency. The remainder of this executive summary examines the transformational shifts, segmentation nuances, regional differences, corporate responses, and strategic recommendations that leaders must weigh when engaging this dynamic market.

An analysis of the pivotal technological, clinical, and commercial shifts that are redefining point-of-care veterinary diagnostics and industry business models

The landscape of veterinary point-of-care diagnostics is undergoing transformative shifts that reconfigure value chains, clinical workflows, and investment priorities. One prominent change is the migration from single-use lateral flow devices toward more sophisticated reader-based and reader-less formats that enable quantitative outputs, connectivity, and result standardization. This shift supports integration with practice management systems and teletriage services, allowing clinicians to make data-driven decisions with confidence and to extend diagnostic reach into remote and ambulatory settings.

Simultaneously, molecular diagnostics are moving out of centralized labs and into near-patient environments, driven by simplified sample preparation, isothermal amplification methods, and cartridgeized consumables. The democratization of higher-sensitivity tests alters diagnostic pathways for infectious disease management in both companion animals and livestock, enabling faster containment and targeted therapeutics. Artificial intelligence and cloud analytics are adding a layer of interpretation to raw outputs, helping clinicians prioritize cases and identify epidemiological signals earlier.

As business models evolve, manufacturers and distributors are adopting service-centric approaches that bundle instruments with reagents, calibration services, and digital subscriptions to lock in lifetime value and improve predictability. These shifts are forcing legacy vendors to accelerate innovation cycles and newer entrants to demonstrate clinical validation, regulatory compliance, and cost-effective service operations. The aggregate result is a more connected, agile, and clinically impactful diagnostic ecosystem for animal health.

How the 2025 tariff adjustments reshaped supply chains, pricing strategies, and procurement choices across veterinary diagnostic equipment and consumables

The cumulative impact of tariff changes implemented in 2025 has materially influenced procurement strategies, pricing mechanisms, and supply chain resilience across the veterinary diagnostics ecosystem. Tariff dynamics have increased the landed cost of imported analyzers, reader modules, and critical reagent inputs that are often manufactured in highly specialized overseas facilities. For end users operating on tight margins, such as ambulatory clinics and small diagnostic laboratories, incremental cost increases create pressure to reprice services or lengthen replacement cycles for capital equipment.

Manufacturers and distributors responded by accelerating localization and dual-sourcing strategies. Some moved production of high-volume consumables to regional contract manufacturers, while others prioritized inventory hedging and multi-tier distribution to buffer short-term volatility. These maneuvers improved responsiveness but increased working capital requirements and added complexity to inventory management. In parallel, tariff-related cost pressures incentivized product redesigns that reduced reliance on tariffed components and optimized supply chains for modular assembly closer to major end-user markets.

From a market access viewpoint, tariff changes encouraged a sharper segmentation of value propositions. Vendors emphasized total cost of ownership, service reliability, and integrated consumables bundles to justify pricing in tariff-inflated environments. The net effect is a more defensive and strategically diversified industry posture, with opportunities for regional manufacturers to capture share where local production can undercut tariff-affected imports and for agile suppliers to offer differentiated service and subscription models that dampen immediate price sensitivity.

A comprehensive set of segmentation insights tying animal species, diagnostic modalities, end-user profiles, and sample pathways to actionable product and channel strategies

Key segmentation insights emerge when the market is examined through multiple lenses that reflect clinical, technological, and commercial realities. By animal type, demand patterns bifurcate between companion animals and livestock; within the companion segment, cats and dogs exhibit distinct diagnostic use cases driven by differences in caregiver expectations and clinical presentation, while livestock demands-spanning cattle, horses, poultry, and swine-tend to prioritize throughput, biosecurity, and batch testing workflows. These divergent needs affect kit formulation, analyzer throughput, and service models.

When tests are disaggregated by type, biochemistry solutions, which include chemistry analyzers and electrolyte analyzers, remain foundational for routine metabolic screening and critical care. Hematology instruments such as cell counters and hemoglobin analyzers are core to anemia workup and infection monitoring. Immunoassays continue to serve as rapid, easy-to-use screens delivered via ELISA formats or lateral flow assays, while molecular diagnostics provide higher sensitivity and specificity for pathogen detection in outbreak scenarios.

End users skew across diagnostic laboratories, hospitals and clinics, and research institutes, each with different procurement cycles, validation requirements, and budget horizons. Technology choices split between reader-based systems that deliver quantitation and connectivity, and reader-less formats that prioritize simplicity and low cost. Applications span cardiac monitoring, critical care, infectious disease detection, and metabolic screening, with sample types commonly including blood, feces, milk, saliva, and urine. Understanding how these segmentation axes intersect is central to product design and go-to-market prioritization because the optimal combination of analyzer capability, consumable format, and service offering varies significantly by animal type, test purpose, and care setting.

A regionally differentiated view highlighting the distinct clinical demands, regulatory nuances, and commercial pathways across major global territories

Regional dynamics shape adoption curves, regulatory pathways, and commercial priorities in ways that vendors and investors must account for when planning market entry and expansion. In the Americas, demand is concentrated around advanced companion animal care and integrated clinic workflows, supported by strong private veterinary practice networks and a willingness among owners to invest in premium diagnostics. Market participants in this region emphasize instrument performance, digital integration, and bundled consumables as differentiators, and there is growing momentum for telehealth-enabled diagnostic services.

Across Europe, the Middle East & Africa, purchasers face a diverse landscape marked by high variability in regulatory frameworks, reimbursement norms, and veterinary service infrastructure. Western European markets trend toward clinical sophistication and regulation-driven validation requirements, while certain Middle Eastern and African markets prioritize ruggedness, cost efficiency, and simplified training models. These regional contrasts require tailored product lines and flexible commercial terms to accommodate heterogeneous procurement capabilities and clinical practices.

In the Asia-Pacific region, high population densities, expanding livestock operations, and rising companion animal ownership create strong demand for scalable diagnostics. Several markets show rapid adoption of mobile-enabled diagnostics and cloud analytics, and a robust local manufacturing base in some countries has supported faster rollout of cost-competitive consumables. Overall, regional strategies must balance global technology platforms with localized product adaptations, regulatory alignment, and distribution partnerships to achieve sustainable penetration.

A strategic assessment of how incumbents, specialized veterinary firms, and innovative startups are competing and collaborating to capture value across instruments, consumables, and services

The corporate landscape in veterinary point-of-care diagnostics is characterized by a blend of established diagnostics providers, specialized veterinary focused firms, and nimble startups, each pursuing different routes to scale. Incumbent device manufacturers leverage established distribution networks and service capabilities to upsell integrated instrument-and-consumable solutions, while specialized veterinary firms emphasize clinical validation and tailored product design to meet practitioner workflows. Startups frequently focus on single high-value applications, novel assay chemistries, or digital layers that simplify interpretation and reporting.

Strategic activity centers on partnerships, licensing, and co-development agreements that accelerate time to market while spreading development risk. Common approaches include collaborations with veterinary hospital groups to pilot new diagnostics, agreements with contract manufacturers to regionalize production, and alliances with software providers to embed connectivity and analytics into clinical routines. Competitive differentiation increasingly relies on the ability to deliver end-to-end value: reliable hardware, validated consumables, responsive service, and data tools that drive clinical utility.

Firms that secure long-term service contracts, optimize reagent logistics, and provide targeted clinician education programs tend to achieve higher retention and improved lifetime revenue. Conversely, companies that underinvest in local support or fail to demonstrate clear clinical advantages face protracted adoption cycles. For stakeholders evaluating partnerships, emphasis should be placed on operational readiness, quality systems, and the ability to support multi-species validation to maximize cross-segment applicability.

Actionable strategic recommendations for vendors and investors to strengthen product portfolios, supply chains, service models, and regulatory engagement in veterinary diagnostics

Industry leaders can accelerate adoption and secure durable advantage by implementing a focused set of strategic actions. First, prioritize product architectures that offer modularity: platforms capable of supporting multiple assay types and sample matrices reduce per-unit risk and increase life cycle revenues. Investing in reader-less formats for low-cost, high-volume use while maintaining reader-based offerings for quantitative and connected workflows enables broader market coverage and pricing flexibility.

Second, strengthen supply chain resilience through regional manufacturing partnerships and multilateral sourcing agreements that reduce exposure to tariff volatility and logistical disruption. Embedding local assembly and regional reagent production can shorten lead times and improve margin stability. Third, differentiate through service models that integrate training, calibration, and digital interpretive support; subscription-based consumable plans that include automatic replenishment and remote monitoring improve customer retention and stabilize revenue forecasts.

Fourth, engage proactively with regulators and key opinion leaders to accelerate clinical validation and create clear pathways for market access. Fifth, align commercial models to end-user economics by offering tiered instruments, bundled consumables, and flexible financing to accommodate varied budget profiles across veterinary clinics, diagnostic laboratories, and research institutes. Finally, embed data capabilities to convert diagnostic outputs into actionable practice intelligence and population health insights, thereby reinforcing the value proposition for buyers and payers alike.

A transparent outline of primary and secondary research approaches, expert validation processes, and data triangulation techniques used to build actionable intelligence

The research methodology underpinning this analysis combines primary qualitative inquiry with rigorous secondary validation to ensure findings are clinically relevant and operationally grounded. Primary research included structured interviews with practicing veterinarians, laboratory directors, livestock production managers, and product development leaders, focusing on use cases, procurement decision criteria, and post-purchase support expectations. These conversations provided real-world context for product acceptance, workflow integration, and pain points associated with existing diagnostic offerings.

Secondary research drew on technical literature, regulatory guidance documents, patents, and publicly available clinical validation studies to corroborate performance claims and identify technology trajectories. Data triangulation was employed to reconcile differing perspectives across stakeholder groups and to validate trends observed in practice. Segmentation analyses were performed by cross-referencing clinical use cases with instrumentation capabilities and consumables formats to determine where product fit aligns with end-user needs.

Limitations of the methodology include variability in regulatory transparency across regions and differing levels of adoption maturity across animal types, which can affect the generalizability of some tactical conclusions. To mitigate these constraints, findings were stress-tested through scenario analysis and subjected to peer review by independent industry experts, enhancing the robustness of the recommendations presented.

A conclusive synthesis emphasizing the interplay of technology, service delivery, and operational resilience that will determine long-term success in veterinary diagnostics

In conclusion, veterinary point-of-care diagnostics are entering a phase of practical maturation where technological capability, service design, and commercial agility determine winners and losers. The convergence of portable molecular tools, improved immunoassay formats, and digital interpretation platforms provides a clear pathway for diagnostics to move from episodic use toward routine integration in both companion animal clinics and livestock operations. However, sustained adoption depends on addressing end-user economics, building resilient supply chains, and demonstrating measurable clinical utility across multi-species contexts.

Organizations that combine modular product design with strong local support, intelligent service models, and partnerships that accelerate regulatory acceptance will be best positioned to capture durable value. Tariff pressures and regional variability underscore the need for flexible manufacturing footprints and adaptive commercial terms. Ultimately, the most compelling value propositions will be those that translate rapid, accurate diagnostics into improved clinical outcomes, reduced operational waste, and enhanced population health surveillance, thereby making point-of-care testing indispensable across animal health practice.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of AI-powered image analysis in handheld veterinary diagnostics to enhance accuracy and speed
  • 5.2. Rising adoption of multiplex immunoassay cartridges for comprehensive on-site disease panels in companion animals
  • 5.3. Expansion of portable molecular testing platforms enabling rapid detection of zoonotic pathogens in field conditions
  • 5.4. Increased investment in wireless connectivity features for real-time remote monitoring and telemedicine in veterinary clinics
  • 5.5. Deployment of smartphone-based diagnostic sensors for early detection of metabolic disorders in livestock
  • 5.6. Growing emphasis on point-of-care biochemical analyzers with minimal sample volume for neonatal and exotic pets
  • 5.7. Collaboration between agtech and veterinary diagnostics firms to develop sensor arrays for herd health management
  • 5.8. Development of battery-operated microfluidic devices for on-farm detection of antimicrobial resistance markers
  • 5.9. Surge in availability of cloud-based analytics integrating POC data with electronic health records for trend analysis within veterinary practice

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Veterinary Point Of Care Diagnostics Market, by Animal Type

  • 8.1. Companion Animals
    • 8.1.1. Cats
    • 8.1.2. Dogs
  • 8.2. Livestock
    • 8.2.1. Cattle
    • 8.2.2. Horses
    • 8.2.3. Poultry
    • 8.2.4. Swine

9. Veterinary Point Of Care Diagnostics Market, by Test Type

  • 9.1. Biochemistry
    • 9.1.1. Chemistry Analyzer
    • 9.1.2. Electrolyte Analyzer
  • 9.2. Hematology
    • 9.2.1. Cell Counter
    • 9.2.2. Hemoglobin Analyzer
  • 9.3. Immunoassay
    • 9.3.1. Elisa
    • 9.3.2. Lateral Flow Assay
  • 9.4. Molecular Diagnostics

10. Veterinary Point Of Care Diagnostics Market, by End User

  • 10.1. Diagnostic Laboratories
  • 10.2. Hospitals And Clinics
  • 10.3. Research Institutes

11. Veterinary Point Of Care Diagnostics Market, by Technology

  • 11.1. Reader Based
  • 11.2. Reader Less

12. Veterinary Point Of Care Diagnostics Market, by Application

  • 12.1. Cardiac Monitoring
  • 12.2. Critical Care
  • 12.3. Infectious Disease
  • 12.4. Metabolic Screening

13. Veterinary Point Of Care Diagnostics Market, by Sample Type

  • 13.1. Blood
  • 13.2. Feces
  • 13.3. Milk
  • 13.4. Saliva
  • 13.5. Urine

14. Veterinary Point Of Care Diagnostics Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Veterinary Point Of Care Diagnostics Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Veterinary Point Of Care Diagnostics Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. IDEXX Laboratories, Inc.
    • 17.3.2. Zoetis Inc.
    • 17.3.3. Heska Corporation
    • 17.3.4. Abaxis, Inc.
    • 17.3.5. Mars, Inc.
    • 17.3.6. FUJIFILM Holdings Corporation
    • 17.3.7. Nova Biomedical Corporation
    • 17.3.8. bioMerieux SA
    • 17.3.9. Abbott Laboratories
    • 17.3.10. QIAGEN N.V.

LIST OF FIGURES

  • FIGURE 1. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. VETERINARY POINT OF CARE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. VETERINARY POINT OF CARE DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. VETERINARY POINT OF CARE DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CATS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CATS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CATS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CATS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CATS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CATS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY DOGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY DOGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY DOGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY DOGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY DOGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY DOGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CATTLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CATTLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CATTLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CATTLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CATTLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CATTLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HORSES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HORSES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HORSES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HORSES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HORSES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HORSES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY POULTRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY POULTRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY POULTRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY POULTRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY POULTRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY POULTRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SWINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SWINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SWINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SWINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SWINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SWINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CHEMISTRY ANALYZER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CHEMISTRY ANALYZER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CHEMISTRY ANALYZER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CHEMISTRY ANALYZER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CHEMISTRY ANALYZER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CHEMISTRY ANALYZER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ELECTROLYTE ANALYZER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ELECTROLYTE ANALYZER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ELECTROLYTE ANALYZER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ELECTROLYTE ANALYZER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ELECTROLYTE ANALYZER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ELECTROLYTE ANALYZER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CELL COUNTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CELL COUNTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CELL COUNTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CELL COUNTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CELL COUNTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CELL COUNTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMOGLOBIN ANALYZER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMOGLOBIN ANALYZER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMOGLOBIN ANALYZER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMOGLOBIN ANALYZER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMOGLOBIN ANALYZER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMOGLOBIN ANALYZER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ELISA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ELISA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ELISA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ELISA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ELISA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ELISA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY READER BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY READER BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY READER BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY READER BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY READER BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY READER BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY READER LESS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY READER LESS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY READER LESS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY READER LESS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY READER LESS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY READER LESS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CARDIAC MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CARDIAC MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CARDIAC MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CARDIAC MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CARDIAC MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CARDIAC MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CRITICAL CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CRITICAL CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CRITICAL CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CRITICAL CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CRITICAL CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CRITICAL CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY METABOLIC SCREENING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY METABOLIC SCREENING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY METABOLIC SCREENING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY METABOLIC SCREENING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY METABOLIC SCREENING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY METABOLIC SCREENING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BLOOD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BLOOD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BLOOD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BLOOD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BLOOD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BLOOD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY FECES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY FECES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY FECES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY FECES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY FECES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY FECES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY MILK, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY MILK, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY MILK, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY MILK, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY MILK, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY MILK, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SALIVA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SALIVA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SALIVA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SALIVA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SALIVA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SALIVA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY URINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY URINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY URINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY URINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY URINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY URINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 221. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 222. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 223. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 224. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 225. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 226. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 227. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
  • TABLE 228. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2025-2032 (USD MILLION)
  • TABLE 229. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
  • TABLE 230. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
  • TABLE 231. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, 2018-2024 (USD MILLION)
  • TABLE 232. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, 2025-2032 (USD MILLION)
  • TABLE 233. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2024 (USD MILLION)
  • TABLE 234. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2025-2032 (USD MILLION)
  • TABLE 235. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
  • TABLE 236. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2025-2032 (USD MILLION)
  • TABLE 237. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 238. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 239. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 240. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 241. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 242. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 243. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 245. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 248. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 250. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 251. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
  • TABLE 252. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2025-2032 (USD MILLION)
  • TABLE 253. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
  • TABLE 254. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
  • TABLE 255. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, 2018-2024 (USD MILLION)
  • TABLE 256. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, 2025-2032 (USD MILLION)
  • TABLE 257. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2024 (USD MILLION)
  • TABLE 258. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2025-2032 (USD MILLION)
  • TABLE 259. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
  • TABLE 260. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2025-2032 (USD MILLION)
  • TABLE 261. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 262. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 263. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 264. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 265. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 266. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 267. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 269. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 273. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 274. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 275. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
  • TABLE 276. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2025-2032 (USD MILLION)
  • TABLE 277. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
  • TABLE 278. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
  • TABLE 279. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, 2018-2024 (USD MILLION)
  • TABLE 280. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, 2025-2032 (USD MILLION)
  • TABLE 281. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2024 (USD MILLION)
  • TABLE 282. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET